Students from laboratories affiliated with the Genetics, Genomics and Bioinformatics graduate program (GGB) shared their findings during the fifth annual GGB Research Day.
M. Aleksander Wysocki has been elected to full membership in Sigma Xi. Wysocki is a doctoral candidate in the Computational Cell Biology, Anatomy and Pathology program.
New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.
M. Aleksander Wysocki and Beatriz Santaella Luna were invited to present research in the “Building a Phenomic Universe: Collection, Management and Applications of Digital Morphological Data” symposium.
New information from Department of Biochemistry researchers on how manganese gets into the brain is helping to shed light on a neurological disorder usually associated with industrial overexposure to the metal.
Research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified a new drug target for remyelination in multiple sclerosis (MS).
Researchers and their mentors in the Department of Pharmacology and Toxicology were honored for their in-depth studies presented at the 2018 Experimental Biology meeting and related forums.
Thirteen students from the Class of 2017-18 in the PhD Program in Biomedical Sciences (PPBS) took part in a white coat ceremony to recognize the completion of their first year in the program and celebrate their moving on to a research laboratory match.
The Office of Inclusion and Cultural Enhancement recognized staff, students, trainees and faculty during the 2018 Faculty-Staff Recognition Awards ceremony.
Vincent M. Tutino, PhD, a recent graduate of the doctoral program in biomedical engineering, is first author on a published study in PLOS ONE showing that circulating cells in the blood carry a gene expression “signature” that may predict if someone has a brain aneurysm.
Research led by senior author David Dietz, PhD, has revealed that in certain types of brain cells, drug-induced plasticity can work to reduce motivation for heroin.
Daniel J. Kosman, PhD, SUNY Distinguished Professor of biochemistry, has been awarded a five-year, $1.96 million grant that may lead to advances in understanding the progression of Alzheimer’s disease.
Seventy-six student-scientists presented projects during the 2017 Buffalo Summer Research Day, an interdisciplinary forum marking the culmination of their summer research in Buffalo.
Three residents provided presentations concentrating on retinal diseases and treatment at a symposium sponsored by the Department of Ophthalmology and the Ross Eye Institute.
Trainees and a student in the departments of Medicine, Hematology/Oncology, Biomedical Engineering and Pediatrics have received awards for their research.
Applicants are required to apply to the PhD Program in Biomedical Sciences through Graduate School Application Manager, UB's electronic application system.
